0.9(top 50%)
impact factor
190(top 50%)
papers
1.1K(top 50%)
citations
18(top 50%)
h-index
0.9(top 50%)
impact factor
209
all documents
1.2K
doc citations
27(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Management of Gastrointestinal Involvement in SclerodermaCurrent Treatment Options in Rheumatology201564
2Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available TreatmentCurrent Treatment Options in Rheumatology201653
3Neurological Complications of Sjögren’s Syndrome: Diagnosis and ManagementCurrent Treatment Options in Rheumatology201745
4Giant Cell Arteritis: From Pathogenesis to Therapeutic ManagementCurrent Treatment Options in Rheumatology201642
5Pharmacologic and Non-Pharmacologic Treatment of OsteoarthritisCurrent Treatment Options in Rheumatology201640
6Current Treatment for MyositisCurrent Treatment Options in Rheumatology201836
7Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic TreatmentCurrent Treatment Options in Rheumatology202035
8What Does the COVID-19 Pandemic Mean for Rheumatology Patients?Current Treatment Options in Rheumatology202035
9Weathering the Storm: Improving Therapeutic Interventions for Cytokine Storm Syndromes by Targeting Disease PathogenesisCurrent Treatment Options in Rheumatology201733
10Osteoporosis Management in Ankylosing SpondylitisCurrent Treatment Options in Rheumatology201631
11An Update on Treatment of Pediatric Chronic Non-infectious UveitisCurrent Treatment Options in Rheumatology201731
12An Update on the Treatment of Pediatric Autoimmune EncephalitisCurrent Treatment Options in Rheumatology201831
13Avoidance of Harm From Treatment for ANCA-Associated VasculitisCurrent Treatment Options in Rheumatology201730
14The Risk Benefit Ratio of Glucocorticoids in SLE: Have Things Changed over the Past 40 years?Current Treatment Options in Rheumatology201729
15Exercise in MyositisCurrent Treatment Options in Rheumatology201823
16Myositis-Related Interstitial Lung Diseases: Diagnostic Features, Treatment, and ComplicationsCurrent Treatment Options in Rheumatology201923
17Scleroderma MimickersCurrent Treatment Options in Rheumatology201621
18Current Evidence-Based Interdisciplinary Treatment Options for Pediatric Musculoskeletal PainCurrent Treatment Options in Rheumatology201820
19Juvenile Dermatomyositis: New Clues to Diagnosis and TherapyCurrent Treatment Options in Rheumatology202120
20Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung DiseaseCurrent Treatment Options in Rheumatology202117
21Rituximab: the Lupus JourneyCurrent Treatment Options in Rheumatology201516
22Autoantibodies and Their Role in Scleroderma Clinical CareCurrent Treatment Options in Rheumatology201616
23Gout and Hyperuricemia: an Historical PerspectiveCurrent Treatment Options in Rheumatology201515
24Addressing Mental Health in Pediatric RheumatologyCurrent Treatment Options in Rheumatology201814
25The Role of Vascular Imaging to Advance Clinical Care and Research in Large-Vessel VasculitisCurrent Treatment Options in Rheumatology201914
26An Update on Treatment of Kawasaki DiseaseCurrent Treatment Options in Rheumatology201914
27Management of Widespread Pain and FibromyalgiaCurrent Treatment Options in Rheumatology201613
28Management of Calcinosis Associated with Systemic SclerosisCurrent Treatment Options in Rheumatology201612
29The Role of Patient-Reported Outcomes in Systemic Lupus ErythematosusCurrent Treatment Options in Rheumatology201712
30Pharmacotherapy Options in the Management of Raynaud’s PhenomenonCurrent Treatment Options in Rheumatology201812
31Lymphoma in Sjögren’s Syndrome: Predictors and Therapeutic OptionsCurrent Treatment Options in Rheumatology202012
32Efficacy and Safety of Platelet-Rich Plasma Injections for OsteoarthritisCurrent Treatment Options in Rheumatology202012
33The Importance of Hip Shape in Predicting Hip OsteoarthritisCurrent Treatment Options in Rheumatology201811
34Evaluation and Treatment of Childhood Enthesitis-Related ArthritisCurrent Treatment Options in Rheumatology201510
35Measuring Disease Progression in OsteoarthritisCurrent Treatment Options in Rheumatology201610
36Knee and Hip Osteoarthritis Management: A Review of Current and Emerging Non-Pharmacological ApproachesCurrent Treatment Options in Rheumatology201610
37Management of Renal Involvement in SclerodermaCurrent Treatment Options in Rheumatology20159
38Self-Efficacy and the Role of Non-pharmacologic Treatment Strategies to Improve Pain and Affect in ArthritisCurrent Treatment Options in Rheumatology20199
39Challenges and Advances in SLE Autoantibody Detection and InterpretationCurrent Treatment Options in Rheumatology20199
40Therapeutic Management of Immune-Mediated Necrotizing MyositisCurrent Treatment Options in Rheumatology20219
41Dysregulation of Type I Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?Current Treatment Options in Rheumatology20219
42TNF and IL-1 Targeted Treatment in Kawasaki DiseaseCurrent Treatment Options in Rheumatology20168
43Management of Musculoskeletal Involvement in Systemic SclerosisCurrent Treatment Options in Rheumatology20168
44Cutaneous Lupus Erythematosus: Current Treatment OptionsCurrent Treatment Options in Rheumatology20168
45Treatment Advances in Chronic Non-Bacterial Osteomyelitis and Other Autoinflammatory Bone ConditionsCurrent Treatment Options in Rheumatology20178
46Novel Therapeutic Targets in Axial SpondyloarthritisCurrent Treatment Options in Rheumatology20188
47Insight into the Contrasting Findings of Therapeutic Trials of Digital Ischaemic Manifestations of Systemic SclerosisCurrent Treatment Options in Rheumatology20198
48An Update on Targets for Treating Osteoarthritis Pain: NGF and TRPV1Current Treatment Options in Rheumatology20208
49Outcome Measures for Gout Clinical Trials: a Summary of ProgressCurrent Treatment Options in Rheumatology20157
50Clinical Trials in VasculitisCurrent Treatment Options in Rheumatology20167